0001209191-17-002803.txt : 20170106 0001209191-17-002803.hdr.sgml : 20170106 20170106210714 ACCESSION NUMBER: 0001209191-17-002803 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170104 FILED AS OF DATE: 20170106 DATE AS OF CHANGE: 20170106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immune Design Corp. CENTRAL INDEX KEY: 0001437786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262007174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVE. E STREET 2: SUITE 310 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 682-0645 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVE. E STREET 2: SUITE 310 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: VACCSYS INC DATE OF NAME CHANGE: 20080617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALTIMORE DAVID CENTRAL INDEX KEY: 0001185858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36561 FILM NUMBER: 17515594 MAIL ADDRESS: STREET 1: AMGEN INC. STREET 2: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-04 0 0001437786 Immune Design Corp. IMDZ 0001185858 BALTIMORE DAVID CIO IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E., SUITE 310 SEATTLE WA 98102 1 0 0 0 Stock Option (right to buy) 5.60 2017-01-04 4 A 0 10000 0.00 A 2027-01-04 Common Stock 10000 10000 D The shares underlying the option will become fully vested on January 4, 2018, subject to the Reporting Person's continuous service through such date. /s/ Stephen R. Brady, Attorney-in-Fact 2017-01-06